| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.05 |